Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,302,064
+$210,732 QoQ
Shares Held
25,697
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#1,283
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Advisors, LLC holds $18,785,727 across 8 Drug Manufacturers - General names. MRK ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,304 | $7,561,207 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
25,697 | $3,302,064 | |
| 3 | AMGN |
Amgen Inc
|
8,375 | $3,032,755 | |
| 4 | JNJ |
Johnson & Johnson
|
11,076 | $2,812,971 | |
| 5 | PFE |
Pfizer Inc
|
42,564 | $1,024,941 | |
| 6 | NVS |
Novartis AG
|
2,601 | $407,628 | |
| 7 | ABBV |
AbbVie Inc.
|
1,502 | $377,963 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,107 | $266,198 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,302,064 | 25,697 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,091,332 | 25,699 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,700,250 | 54,154 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,571,163 | 54,464 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,197,617 | 53,027 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,829,985 | 53,810 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $5,042,541 | 50,689 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,961,672 | 52,498 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $6,708,598 | 54,189 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $6,808,356 | 51,598 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,351,573 | 49,088 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,910,509 | 47,698 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,293,516 | 45,875 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $5,137,466 | 48,289 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $5,358,552 | 48,297 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $4,103,015 | 47,643 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,287,360 | 47,026 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $3,589,851 | 43,752 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,963,898 | 38,673 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,752,481 | 36,646 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,738,359 | 35,211 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,343,691 | 30,402 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,963,035 | 23,998 | Shares | Sole | 2021-05-07 | |
| 2020-09-30 | $1,773,637 | 21,382 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,562,453 | 20,205 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,452,395 | 18,877 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||